04/10/2021

Environmental Protection Test Report for the First Quarter of 2021

Environmental Protection Test Report for the First Quarter of 2021

07/03/2021

Environmental Protection Test Report for the Second Quarter of 2021

Environmental Protection Test Report for the Second Quarter of 2021

01/21/2022

2020 New Drug Registration Clinical Trial Status Report Released

A few days ago, the Center for Drug Evaluation of the State Food and Drug Administration released the "Annual Report on the Status of Clinical Trials of New Drug Registration in China (2020)" (hereinafter referred to as the "Report"). Based on the registration information of the 2020 drug clinical trial registration and information publicity platform, the "Report" is the first to conduct a comprehensive summary and analysis of the current status of new drug registration clinical trials in my country.

01/21/2022

Negotiation, centralized procurement... The reform of the medical insurance system has profoundly adjusted the pharmaceutical market

A few days ago, the reporter learned from the conference site of the "Blue Book on the Progress and Effectiveness of China's Medical Insurance Drug Administration Reform" (hereinafter referred to as the "Blue Book") that my country has carried out the adjustment of the National Medical Insurance Drug Catalog for three consecutive years since 2018. Reimbursement has reduced the burden on patients by nearly 170 billion yuan. Since the centralized procurement reform in 2018, as of September 2021, the accumulated cost savings is about 250 billion yuan.

01/21/2022

Homogenization of new drug target research "involution", will pediatric drugs be the next outlet?

Recently, the Center for Drug Evaluation (CDE) of the State Drug Administration released the "Annual Report on the Status of Clinical Trials of New Drug Registration in China (2020)" (hereinafter referred to as the "Report"), which is the first comprehensive summary of the current status of clinical trials of new drug registration in China. An analysis report.

01/21/2022

A new round of medical insurance negotiations is about to start, and 20 innovative drugs may participate in the negotiations for the first time

According to reports, the 2021 national medical insurance negotiation will start on November 9 and end on November 11. The negotiation will last for three days. With the launch of a new round of medical insurance negotiations, which blockbuster new drugs will receive tickets to the medical insurance catalogue have attracted much attention.